CN112970992A - 一种适合糖尿病人的固体饮料及制作方法 - Google Patents
一种适合糖尿病人的固体饮料及制作方法 Download PDFInfo
- Publication number
- CN112970992A CN112970992A CN202110026947.XA CN202110026947A CN112970992A CN 112970992 A CN112970992 A CN 112970992A CN 202110026947 A CN202110026947 A CN 202110026947A CN 112970992 A CN112970992 A CN 112970992A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaves
- raw materials
- diabetics
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 51
- 239000007787 solid Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 59
- 241000234435 Lilium Species 0.000 claims abstract description 26
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 25
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 25
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 25
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 25
- 241001018563 Nekemias grossedentata Species 0.000 claims abstract description 25
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 24
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 23
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 23
- 240000000249 Morus alba Species 0.000 claims abstract description 22
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 22
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 22
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 22
- 241001523681 Dendrobium Species 0.000 claims abstract description 21
- 235000021018 plums Nutrition 0.000 claims abstract description 19
- 241000222336 Ganoderma Species 0.000 claims abstract description 18
- 241001633106 Lithocarpus Species 0.000 claims abstract description 8
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241001365741 Lithocarpus litseifolius Species 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 23
- 235000019640 taste Nutrition 0.000 abstract description 11
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 210000004072 lung Anatomy 0.000 description 10
- 230000035922 thirst Effects 0.000 description 10
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 7
- 241001489091 Ganoderma sinense Species 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 244000248557 Ophiopogon japonicus Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000003674 animal food additive Substances 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000010415 tropism Effects 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 241000269420 Bufonidae Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 102000001105 Phosphofructokinases Human genes 0.000 description 1
- 108010069341 Phosphofructokinases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241001629703 Pueraria candollei var. mirifica Species 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000601022 Salix scouleriana Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- -1 oxygen free radical Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种适合糖尿病人的固体饮料及制作方法，包括下列原料按照重量份数配制而成：桑叶15‑20份，显齿蛇葡萄叶15‑20份，青钱柳叶8‑12份，木姜叶柯8‑12份，葛根3‑5份，山药2‑4份，乌梅6‑8份，酸枣仁4‑6，紫灵芝4‑6，杭麦冬6‑8份，西洋参4‑6份，百合2‑4份，石斛3‑5份。本发明采用传统的中药为原料配制成适合糖尿病人的保健饮料，具有副作用小，口感好，能够降低糖尿病人血糖的优点。本发明还提供了一种适合糖尿病人的保健饮料的制作方法。
Description
技术领域
本发明涉及糖尿病保健饮料领域，尤其涉及一种适合糖尿病人的固体饮 料及制作方法。
背景技术
世界各国糖尿病的发病率正在逐年增加。据世界卫生组织有关资料表明， 全球糖尿病患者已经超过3.82亿，我国糖尿病患者约1.14亿人，糖尿病患者 康复医疗已成为我国医疗卫生工作的重要内容之一。糖尿病是一组以高血糖 为特征的代谢性疾病，高血糖则是由于胰岛素分泌缺陷或生物作用受损或两 者兼有引起的；高血糖及糖尿病的发病有先天遗传和后天因素多种原因，但 主要原因之一，是近年来中国人膳食中能量、蛋白质和脂肪来源明显发生了 变化，纯热能食品、动物性脂肪增加，造成糖尿病的发生呈上升趋势。糖尿病患者长期存在高血糖，从而导致各种组织，特别是眼、肾、心脏、血管、 神经的慢性损害、功能障碍。糖尿病致命的危害可能会并发高血压、高血脂、 骨关节炎、足溃疡等疾病，从而引发失明、肾衰、中风、心梗、截肢等严重 的并发症，致患者残废或早亡。
许多人认为糖尿病只有通过西医才能延缓疾病的继续发展。但是根据长 期临床观察，很多糖尿病患者发病初期服用各种化学性西药，血糖能够快速 的下降，这种下降是暂时和不计后果的，是以阻断人体营养吸收为代价的， 是在药物对机体产生很大的伤害和副作用情况下产生的，其治疗结果都会面 临逐渐增大药物用量，不断换服各种药物，直至药物出现失效的尴尬，上述 方式非但不能使胰岛功能恢复正常，血糖平稳下降，药物的毒副作用在机体 长期积蓄，导致机体更大的伤害，这是引起各种并发症的罪魁祸首。
因此，采用中医食疗法改善病人体质，降低血糖越来越受到中国人的重 视。但传统的中药食法味苦难以下咽，并且需要熬制十分不方便。参照市场 中有推出各种保健型饮料。但是目前的保健饮料通常具有一定的降火滋阴， 养颜作用，却不能适用于糖尿病病人，更没有可以防治糖尿病的饮料。
鉴于此，有必要提供一种新型的适合糖尿病人的固体饮料及制作方法， 以解决或至少缓解上述技术缺陷。
发明内容
本发明的主要目的是提供一种适合糖尿病人的固体饮料及制作方法，旨 在解决现有技术中没有适合于糖尿病人的保健饮料的技术问题。
为实现上述目的，本发明提供一种适合糖尿病人的固体饮料，包括下列 原料按照重量份数配制而成：桑叶15-20份，显齿蛇葡萄叶15-20份，青钱柳 叶8-12份，木姜叶柯8-12份，葛根3-5份，山药2-4份，乌梅6-8份，酸枣 仁4-6，紫灵芝4-6，杭麦冬6-8份，西洋参4-6份，百合2-4份，石斛3-5 份。
可选地，包括下列原料按照重量份数配制而成：桑叶16-18份，显齿蛇葡 萄叶16-18份，青钱柳叶9-11份，木姜叶柯9-11份，葛根3-4份，山药2-3 份，乌梅6-7份，酸枣仁4-5，紫灵芝4-5，杭麦冬7-8份，西洋参4-5份，百 合2-3份，石斛3-4份。
可选地，包括下列原料按照重量份数配制而成：桑叶15份，显齿蛇葡萄 叶15份，青钱柳叶8份，木姜叶柯8份，葛根5份，山药4份，乌梅8份， 酸枣仁6份，紫灵芝5份，杭麦冬6份，西洋参6份，百合4份，石斛5份。
可选地，包括下列原料按照重量份数配制而成：桑叶17份，显齿蛇葡萄 叶17份，青钱柳叶8份，木姜叶柯8份，葛根3份，山药2份，乌梅6份， 酸枣仁5份，紫灵芝4份，杭麦冬6份，西洋参4份，百合2份，石斛3份。
可选地，包括下列原料按照重量份数配制而成：桑叶19份，显齿蛇葡萄 叶19份，青钱柳叶8份，木姜叶柯8份，葛根3份，山药2份，乌梅76份， 酸枣仁6份，紫灵芝4份，杭麦冬8份，西洋参4份，百合3份，石斛4份。
可选地，包括下列原料按照重量份数配制而成：桑叶16份，显齿蛇葡萄 叶16份，青钱柳叶11份，木姜叶柯11份，葛根3份，山药3份，乌梅76 份，酸枣仁5份，紫灵芝5份，杭麦冬8份，西洋参4份，百合4份，石斛5 份。
本发明还提供一种适合糖尿病人的固体饮料的制作方法，用于制作上述 所述的适合糖尿病人的保健饮料，包括以下步骤：
按照重量份数配制的原料混合得到混合原料；
将所述混合原料进行清洗，将清洗干净的混合原料风干后用粗碎机进行 第一次粉碎；
第一次粉碎后搅拌均匀，再经过超微粉碎机进行第二次粉碎，加工成 300-350目的粉末，再次混合机搅拌，经高温灭菌冷却后包装成成品。
可选地，所述按照重量份数配制的原料混合得到混合原料还包括步骤：
向按照重量份数配置的原料中加入甘草6-8份。
本发明还提供一种适合糖尿病人的固体饮料的制作方法，用于制作上述 所述的适合糖尿病人的固体饮料，包括以下步骤：
将按照重量份数配制的原料混合得到混合原料；
将所述混合原料进行清洗，将清洗干净的混合原料风干后用粉碎机进行 粉碎得到粉碎混合料；
向粉碎混合料中加入蒸馏水，所述蒸馏水与所述粉碎混合料的质量比为 15:1，使用常规中药熬制工艺进行熬制，熬制100-120分钟，将熬制完毕的溶 液进行除渣，过滤，得到混合药液；
将所述混合药液加入真空灭菌箱中灭菌，然后降压蒸馏，得到析出的固 体饮料；
将所述固体饮料放入粉碎机中粉碎，高温灭菌冷却后包装成成品。
可选地，所述将熬制完毕的溶液进行除渣，过滤，得到混合药液之后， 所述将所述混合药液加入真空灭菌箱中灭菌之前，还包括步骤：
调味，向所述混合药液中加入木糖醇。
本发明的上述技术方案中，适合糖尿病人的保健饮料包括下列原料按照 重量份数配制而成：桑叶15-20份，显齿蛇葡萄叶15-20份，青钱柳叶8-12 份，木姜叶柯8-12份，葛根3-5份，山药2-4份，乌梅6-8份，酸枣仁4-6， 紫灵芝4-6，杭麦冬6-8份，西洋参4-6份，百合2-4份，石斛3-5份。本发 明采用传统的中药为原料配制成适合糖尿病人的保健饮料，具有副作用小， 口感好，能够降低糖尿病人血糖的优点。
具体实施方式
下面对本发明实施方式中的技术方案进行清楚，完整地描述，显 然，所描述的实施方式仅仅是本发明的一部分实施方式，而不是全部 的实施方式。基于本发明中的实施方式，本领域普通技术人员在没有 作出创造性劳动前提下所获得的所有其他实施方式，都属于本发明保 护的范围。
并且，本发明各个实施方式之间的技术方案可以相互结合，但是必须是 以本领域普通技术人员能够实现为基础，当技术方案的结合出现相互矛盾或 无法实现时应当认为这种技术方案的结合不存在，也不在本发明要求的保护 范围之内。
根据本发明的优选实施方式，发明提供一种适合糖尿病人的保健饮料， 包括下列原料按照重量份数配制而成：桑叶15-20份，显齿蛇葡萄叶15-20份， 青钱柳叶8-12份，木姜叶柯8-12份，葛根3-5份，山药2-4份，乌梅6-8份， 酸枣仁4-6，紫灵芝4-6，杭麦冬6-8份，西洋参4-6份，百合2-4份，石斛 3-5份。该实施例采用传统的中药为原料配制成适合糖尿病人的固体饮料，具 有副作用小，口感好，能够降低糖尿病人血糖的优点。并且，该适合糖尿病人的保健饮料还能起到降血脂和降血压的作用，减小糖尿病并发症的发生。
本发明的药理如下：
显齿蛇葡萄叶：具有调节血糖和降血脂的作用。显齿蛇葡萄有含量较高 的Zn，缺Zn会引起人体生长停滞、贫血、糖尿病和慢性胃炎等，锌还具有 抑制脂质过氧化过程的作用，因此具有防衰老之功效，许多重要的酶类中都 含有锌。另外，显齿蛇葡萄叶中的有效成分二氢杨梅素具有抗氧自由基的作 用，能抑制体内血栓的形成，对降血脂有独特效果。总黄酮具有降血脂、抗 动脉粥样硬化和抑制脂肪肝形成。在临床上用于高血压及冠心病辅助临床治 疗取得明显效果。
桑叶：桑叶中的芸香苷、槲皮素、槲皮苷能增加离体及在位蛙心的收缩 力与输出量，并减少心率。试验中，芸香苷使蟾蜍下肢及兔耳血管收缩，槲 皮素可扩张冠状血管，改善心肌循环。γ-氨基丁酸、芸香苷、槲皮素有降血 压的作用。γ-氨基丁酸是神经传达物质，能促进脑组织的新陈代谢和恢复脑 细胞功能，同时，能改善脑部血液流动，增强血管紧张素转换酶Ⅰ的活性， 促使血压下降。桑叶有抑制脂肪肝的形成、降低血清脂肪和抑制动脉粥样硬 化形成的作用。
青钱柳叶：青钱柳又名摇钱树、甜叶树、甜茶树、山化树、青钱李、山 沟树、山麻柳。落叶乔木，高10-30m。树皮厚，灰色，深纵裂。具有怯风止 痒的功效。
木姜叶柯：被子植物门，嫩枝顶部被微柔毛，嫩叶的侧脉在叶面凹陷， 果序轴密被短柔毛，可用于解毒消炎，降低血糖。
葛根：豆科植物野葛或甘葛藤的干燥根，性味：甘、辛、凉；归经：脾 经；胃经。成分：主要含黄酮类物质，有大豆甙、大豆素、葛根素等。药理 作用：(1)对循环系统的作用，葛根中提出的黄酮能增加脑及冠状血管血流量。 (2)降血糖作用，经试验，葛根水提取物也能使小鼠血糖初上升后下降。(3)解 热作用，经试验，葛根浸剂对人工发热小鼠有明显解热作用。
山药：为薯蓣科植物山药的块茎。性味：甘；平；归经：肺经；脾经； 肾经；功能主治：补脾养胃，生津益肺，补肾涩精。用于脾虚食少、久泻不 止、肺虚喘咳、肾虚遗精、尿频、虚热消渴。药理作用：(1)降血糖作用，试 验中，山药可显著降低正常小鼠和四氧嘧啶糖尿病小鼠的血糖；山药水煎剂 可明显对抗肾上腺素引起的小鼠血糖升高。(2)调节机体对非特异刺激反应。 性作用，能明显减轻小鼠脏器受缺氧环境的损害，提高耐受性。
乌梅：为蔷薇科植物梅的干燥未成熟果实。性味：酸、温；归经：归肝 经、脾经、肺经、大肠经。功能主治：收敛生津，安蛔驱虫。治久咳，虚热 烦渴。药理作用：(1)抗病原生物作用，乌梅对多种致病菌有抑制作用。(2)乌 梅对免疫功能有增强作用。
酸枣仁：为鼠李科植物酸枣的干燥成熟种子。性味：甘、酸、平；归经： 心经、肝经、胆经；功能主治：养肝，宁心，安神，敛汗。治虚烦不眠，惊 悸怔忡，烦渴，虚汗。药理作用：(1)对心血管系统的影响，酸枣仁可引起血 压持续下降，心传导阻滞。(2)镇静、催眠作用：酸枣仁煎剂给大白鼠口服或 腹腔注射均表现镇静及嗜眠，无论白天或黑夜，正常状态或咖啡，因引起的 兴奋状态，酸枣仁均能表现上述作用。(3)镇痛、抗惊厥、降温作用，酸枣仁 煎剂注射于小白鼠腹腔有镇痛作用，对小鼠无论注射或口服均有降温作用。
石斛：味甘、淡、微苦，性微寒。归胃、肺、心、肾经。主入胃肾，作 用重在中下二焦，既清胃热生津止渴，又滋肾阴退热明目，为津伤口渴、生 津止渴。用于热伤津液，烦热口渴良药，多用于津液亏损，内热口渴；胃阴 不足，滋阴清热，养胃生津，润肺止咳，益肾明目。主治热病伤津，虚热不 退，胃阴不足，口干咽燥、脘痛干呕、肺燥咳嗽，腰膝酸软，阴伤目暗。
紫灵芝：具有降血糖作用，降血糖作用的有效成分是紫灵芝中含有的多 糖类物质，作用原理是灵芝多糖抑制四氧嘧啶引起的氧自由基增加和脂质过 氧化反应，保护胰岛B细胞，维持胰岛素分泌处于较正常的水平。紫灵芝还 可以明显提高肝脏葡萄糖激酶、磷酸果糖激酶、葡萄糖-6-磷酸脱氢酶活性， 降低肝糖原含量。另外，紫灵芝对于增强人体免疫力，控制血压，保肝护肝， 促进睡眠等方面均具有显著效果，因此，紫灵芝汁特别适合患有糖尿病的中 老年人服用。
杭麦冬：甘寒清润，善清心肺之热而养阴除烦；用于津伤口渴，内热消渴， 肠燥便秘。有扩张外周血管的作用，能提高耐缺氧能力，有降血糖作用。
西洋参：味甘、微苦，性凉，善清虚火，生津止渴，西洋参滋阴降火。因 此，凡有胃燥津伤的口渴，最适宜用之。能增强体质：抗缺氧，抗疲劳，耐 饥渴，促进造血，降血糖，增强免疫力。
百合：百合其性甘、微寒，归肺、心经可降低血糖、润肺安神、失眠多梦 等症。百合中的蛋白质、氨基酸和多糖可提高人体的免疫力。百合中含有百 合苷，有镇静和催眠的作用。试验证明，每晚睡眠前服用百合汤，有明显改 善睡眠作用，百合高钾、低钠，能预防高血压，有保护血管的作用。百合含 果胶甚丰，能降低血浆中的胆固醇、降低血糖、增进大肠功能、促进排便通 畅。促进蛋白质合成，调节内分泌功能。
通过上述中药成分的混合制作的适合糖尿病人的固体饮料，能够有效降 低糖尿病人的血糖和改善糖尿病人的体质，并且口感好，方便饮用。下面说 明本发明配方的其他具体实施例：
实施例一：桑叶15-20份，显齿蛇葡萄叶15-20份，青钱柳叶8-12份， 木姜叶柯8-12份，葛根3-5份，山药2-4份，乌梅6-8份，酸枣仁4-6，紫灵 芝4-6，杭麦冬6-8份，西洋参4-6份，百合2-4份，石斛3-5份。
实施例二：桑叶16-18份，显齿蛇葡萄叶16-18份，青钱柳叶9-11份， 木姜叶柯9-11份，葛根3-4份，山药2-3份，乌梅6-7份，酸枣仁4-5，紫灵 芝4-5，杭麦冬7-8份，西洋参4-5份，百合2-3份，石斛3-4份。
实施例三：桑叶15份，显齿蛇葡萄叶15份，青钱柳叶8份，木姜叶柯8 份，葛根5份，山药4份，乌梅8份，酸枣仁6份，紫灵芝5份，杭麦冬6 份，西洋参6份，百合4份，石斛5份。
实施例四：桑叶17份，显齿蛇葡萄叶17份，青钱柳叶8份，木姜叶柯8 份，葛根3份，山药2份，乌梅6份，酸枣仁5份，紫灵芝4份，杭麦冬6 份，西洋参4份，百合2份，石斛3份。
实施例五：桑叶19份，显齿蛇葡萄叶19份，青钱柳叶8份，木姜叶柯8 份，葛根3份，山药2份，乌梅76份，酸枣仁6份，紫灵芝4份，杭麦冬8 份，西洋参4份，百合3份，石斛4份。
实施例六：桑叶16份，显齿蛇葡萄叶16份，青钱柳叶11份，木姜叶柯 11份，葛根3份，山药3份，乌梅76份，酸枣仁5份，紫灵芝5份，杭麦冬 8份，西洋参4份，百合4份，石斛5份。
另外，本发明还提供一种适合糖尿病人的固体饮料的制作方法，用于制 作上述的适合糖尿病人的固体饮料，包括以下步骤：
按照重量份数配制的原料混合得到混合原料；
将混合原料进行清洗，将清洗干净的混合原料风干后用粗碎机进行第一 次粉碎；
第一次粉碎后搅拌均匀，再经过超微粉碎机进行第二次粉碎，加工成 300-350目的粉末，再次混合机搅拌，经高温灭菌冷却后包装成成品。
该实施例采用两次或者多次粉碎的方法，将各种中药原料粉碎成超微小 颗粒，保留了中药原料的药性，减小加工过程中对药效的减损，并且加工制 作方便。加工成的成品为固体粉末，服用时倒取粉末，水服或加水冲服即可， 一天三次，每次倒取20g固体粉末配水服下，或者每次倒取20g配100ml温 水冲服。
进一步地，按照重量份数配制的原料混合得到混合原料还包括步骤：
向按照重量份数配置的原料中加入甘草6-8份。甘草用于调和药物的烈 性，并且加入甘草也可以改善口感。
此外，本发明还提供了另一种适合糖尿病人的固体饮料的制作方法，用 于制作上述的适合糖尿病人的固体饮料，包括以下步骤：
将按照重量份数配制的原料混合得到混合原料；
将混合原料进行清洗，将清洗干净的混合原料风干后用粉碎机进行粉碎 得到粉碎混合料；
向粉碎混合料中加入蒸馏水，蒸馏水与粉碎混合料的质量比为15:1，使 用常规中药熬制工艺进行熬制，熬制100-120分钟，将熬制完毕的溶液进行除 渣，过滤，得到混合药液；
将混合药液加入真空灭菌箱中灭菌，然后降压蒸馏，得到析出的固体饮 料；
将固体饮料放入粉碎机中粉碎，高温灭菌冷却后包装成成品。
该实施例通过将中药原料兑水熬制，将中药有效成分溶于液体中后采用 蒸馏或风干使之成为固体后粉碎，服用时没有药渣感，口感更好。服用时加 水冲服即可，一天三次，每次倒取15g固体粉末配100ml水服下。
本发明中将饮料制成固体粉末是为了方便携带，当然，本领域技术人员 完全可以理解，也可以采用上述配方制成适合糖尿病人饮用的液体保健饮料， 只需将上述固体饮料配制一定量的纯净水混合均匀即可。
进一步地，将熬制完毕的溶液进行除渣，过滤，得到混合药液之后，将 混合药液加入真空灭菌箱中灭菌之前，还包括步骤：
调味，向混合药液中加入木糖醇。木糖醇是一种甜味剂，能参与人体代 谢。进入血液后。不需要胰岛素就能渗入细胞，而且代谢速度快，不会引起 血糖升高，是最适合加入糖尿病人食品中的蔗糖替代品，该实施例中中加入 木糖醇调节饮料的甜味，以满足不同消费者的需求。
以上仅为本发明的优选实施例，并非因此限制本发明的专利范围，凡是 在本发明的技术构思下，利用本发明说明书所作的等效结构变换，或直接/间 接运用在其他相关的技术领域均包括在本发明的专利保护范围。
Claims (10)
1.一种适合糖尿病人的固体饮料及制作方法，其特征在于，包括下列原料按照重量份数配制而成：桑叶15-20份，显齿蛇葡萄叶15-20份，青钱柳叶8-12份，木姜叶柯8-12份，葛根3-5份，山药2-4份，乌梅6-8份，酸枣仁4-6，紫灵芝4-6，杭麦冬6-8份，西洋参4-6份，百合2-4份，石斛3-5份。
2.根据权利要求1所述的适合糖尿病人的固体饮料，其特征在于，包括下列原料按照重量份数配制而成：桑叶16-18份，显齿蛇葡萄叶16-18份，青钱柳叶9-11份，木姜叶柯9-11份，葛根3-4份，山药2-3份，乌梅6-7份，酸枣仁4-5，紫灵芝4-5，杭麦冬7-8份，西洋参4-5份，百合2-3份，石斛3-4份。
3.根据权利要求1所述的一种适合糖尿病人的固体饮料及制作方法，其特征在于，包括下列原料按照重量份数配制而成：桑叶15份，显齿蛇葡萄叶15份，青钱柳叶8份，木姜叶柯8份，葛根5份，山药4份，乌梅8份，酸枣仁6份，紫灵芝5份，杭麦冬6份，西洋参6份，百合4份，石斛5份。
4.根据权利要求1所述的一种适合糖尿病人的固体饮料及制作方法，其特征在于，包括下列原料按照重量份数配制而成：桑叶17份，显齿蛇葡萄叶17份，青钱柳叶8份，木姜叶柯8份，葛根3份，山药2份，乌梅6份，酸枣仁5份，紫灵芝4份，杭麦冬6份，西洋参4份，百合2份，石斛3份。
5.根据权利要求1所述的一种适合糖尿病人的固体饮料及制作方法，其特征在于，包括下列原料按照重量份数配制而成：桑叶19份，显齿蛇葡萄叶19份，青钱柳叶8份，木姜叶柯8份，葛根3份，山药2份，乌梅76份，酸枣仁6份，紫灵芝4份，杭麦冬8份，西洋参4份，百合3份，石斛4份，。
6.根据权利要求1所述的一种适合糖尿病人的固体饮料及制作方法，其特征在于，包括下列原料按照重量份数配制而成：桑叶16份，显齿蛇葡萄叶16份，青钱柳叶11份，木姜叶柯11份，葛根3份，山药3份，乌梅76份，酸枣仁5份，紫灵芝5份，杭麦冬8份，西洋参4份，百合4份，石斛5份。
7.一种适合糖尿病人的固体饮料的制作方法，用于制作上述权利要求1-6中任一项所述的适合糖尿病人的固体饮料，其特征在于，包括以下步骤：
按照重量份数配制的原料混合得到混合原料；
将所述混合原料进行清洗，将清洗干净的混合原料风干后用粗碎机进行第一次粉碎；
第一次粉碎后搅拌均匀，再经过超微粉碎机进行第二次粉碎，加工成300-350目的粉末，再次混合机搅拌，经高温灭菌冷却后包装成成品。
8.根据权利要求7所述的适合糖尿病人的固体饮料的制作方法，其特征在于，所述按照重量份数配制的原料混合得到混合原料还包括步骤：
向按照重量份数配置的原料中加入甘草6-8份。
9.一种适合糖尿病人的固体饮料的制作方法，用于制作上述权利要求1-6中任一项所述的适合糖尿病人的保健饮料，其特征在于，包括以下步骤：
将按照重量份数配制的原料混合得到混合原料；
将所述混合原料进行清洗，将清洗干净的混合原料风干后用粉碎机进行粉碎得到粉碎混合料；
向所述粉碎混合料中加入蒸馏水，所述蒸馏水与所述粉碎混合料的质量比为15:1，使用常规中药熬制工艺进行熬制，熬制100-120分钟，将熬制完毕的溶液进行除渣，过滤，得到混合药液；
将所述混合药液加入真空灭菌箱中灭菌，然后降压蒸馏，得到析出的固体饮料；
将所述固体饮料放入粉碎机中粉碎，高温灭菌冷却后包装成成品。
10.根据权利要求9所述的适合糖尿病人的保健饮料的制作方法，其特征在于，所述将熬制完毕的溶液进行除渣，过滤，得到混合药液之后，所述将所述混合药液加入真空灭菌箱中灭菌之前，还包括步骤：
调味，向所述混合药液中加入木糖醇。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110026947.XA CN112970992A (zh) | 2021-01-09 | 2021-01-09 | 一种适合糖尿病人的固体饮料及制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110026947.XA CN112970992A (zh) | 2021-01-09 | 2021-01-09 | 一种适合糖尿病人的固体饮料及制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112970992A true CN112970992A (zh) | 2021-06-18 |
Family
ID=76345318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110026947.XA Pending CN112970992A (zh) | 2021-01-09 | 2021-01-09 | 一种适合糖尿病人的固体饮料及制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112970992A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113648387A (zh) * | 2021-08-20 | 2021-11-16 | 成都韦斯卡生物科技有限公司 | 一种修护β胰岛细胞、降糖的植萃液及制备方法、应用 |
| CN113875864A (zh) * | 2021-10-27 | 2022-01-04 | 江门市方程健康生物科技有限公司 | 一种降血糖抑糖茶及其制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101003775A (zh) * | 2006-12-28 | 2007-07-25 | 姚茂君 | 一种显齿蛇葡萄保健茶酒的生产方法及其产品 |
| CN101828738A (zh) * | 2010-05-10 | 2010-09-15 | 王雄 | 防治糖尿病的保健饮料 |
| CN105265947A (zh) * | 2015-09-10 | 2016-01-27 | 河南爱因糖尿病健康科学研究院股份有限公司 | 一种改善高血糖及糖尿病人体质的植物饮料 |
| CN106261168A (zh) * | 2015-05-11 | 2017-01-04 | 枞阳县靖华生物科技有限公司 | 一种防治糖尿病的保健饮品及其生产工艺 |
| CN109123296A (zh) * | 2018-08-01 | 2019-01-04 | 刘英奎 | 葛根桑叶复合固体饮料及制备方法 |
| CN109966417A (zh) * | 2017-12-28 | 2019-07-05 | 随州市万松堂康汇保健品有限公司 | 一种针对糖尿病人群的固体饮料 |
-
2021
- 2021-01-09 CN CN202110026947.XA patent/CN112970992A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101003775A (zh) * | 2006-12-28 | 2007-07-25 | 姚茂君 | 一种显齿蛇葡萄保健茶酒的生产方法及其产品 |
| CN101828738A (zh) * | 2010-05-10 | 2010-09-15 | 王雄 | 防治糖尿病的保健饮料 |
| CN106261168A (zh) * | 2015-05-11 | 2017-01-04 | 枞阳县靖华生物科技有限公司 | 一种防治糖尿病的保健饮品及其生产工艺 |
| CN105265947A (zh) * | 2015-09-10 | 2016-01-27 | 河南爱因糖尿病健康科学研究院股份有限公司 | 一种改善高血糖及糖尿病人体质的植物饮料 |
| CN109966417A (zh) * | 2017-12-28 | 2019-07-05 | 随州市万松堂康汇保健品有限公司 | 一种针对糖尿病人群的固体饮料 |
| CN109123296A (zh) * | 2018-08-01 | 2019-01-04 | 刘英奎 | 葛根桑叶复合固体饮料及制备方法 |
Non-Patent Citations (3)
| Title |
|---|
| 梅峥嵘编著: "《对症用药及误用辨别手册》", 30 April 2017, 广东科技出版社 * |
| 褚洪标等主编: "《井冈山区域实用中草药图谱》", 31 July 2015, 第四军医大学出版社 * |
| 黄少华等编著: "《我们身边的药用植物》", 31 January 2020, 西南交通大学出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113648387A (zh) * | 2021-08-20 | 2021-11-16 | 成都韦斯卡生物科技有限公司 | 一种修护β胰岛细胞、降糖的植萃液及制备方法、应用 |
| CN113875864A (zh) * | 2021-10-27 | 2022-01-04 | 江门市方程健康生物科技有限公司 | 一种降血糖抑糖茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
| CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
| CN102836379B (zh) | 一种降脂解酒的中药复方制剂及其制备方法与应用 | |
| CN102048224B (zh) | 一种祛黄褐斑美容养颜红枣保健饮料及其生产工艺 | |
| CN111919934A (zh) | 一种用于降三高保护心血管的红花苏心茶及其制备方法 | |
| CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
| CN103520621A (zh) | 一种治疗老年性白内障的中药组合物及其制备方法 | |
| CN112970992A (zh) | 一种适合糖尿病人的固体饮料及制作方法 | |
| CN101518595A (zh) | 具有降脂减肥、抗氧化功能的药物组合物及其制备方法 | |
| CN104958646A (zh) | 一种润肠通便的中药制剂及其制备方法 | |
| CN106723029A (zh) | 一种具有辅助降血糖功能的保健食品及其制备工艺 | |
| CN101011562A (zh) | 参芪温胆汤新剂型及其生产方法 | |
| CN104522213A (zh) | 适宜三高人群饮用的茶饮及其制备方法 | |
| CN105851395A (zh) | 一种黄芪养生茶及其制备方法 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
| CN101062283B (zh) | 降糖茶及其制备方法 | |
| KR100514132B1 (ko) | 체중 감소용 생약 조성물 및 이를 포함하는 체중 감소용 키트 | |
| CN114081928A (zh) | 一种益气生津、降血糖中药组合物及其制备方法 | |
| CN104606570A (zh) | 一种适宜糖尿病患者服用的消渴代茶饮及制备方法 | |
| CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
| CN111905087A (zh) | 一种解酒保肝养生保健品组方 | |
| CN104815140A (zh) | 一种预防或/和治疗糖尿病的组合物及其制备方法 | |
| CN104547494A (zh) | 治疗甲亢的中药组合物药酒及制备工艺 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20220217 Address after: 427100 renchaoxi Town, Sangzhi County, Zhangjiajie City, Hunan Province Applicant after: Hunan selenium lotus Ecological Agriculture Co.,Ltd. Address before: 427000 Economic Development Zone C, Zhangjiajie City, Hunan Province Applicant before: Zhangjiajie Nuokang Ecological Tea Co.,Ltd. |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210618 |